CMS' Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.
If the medical field wants to make serious progress on the Cancer Moonshot effort, it must expand its definition of personalized medicine and explore fresh approaches to cancer prevention, according to Dr. Siddhartha Mukherjee, a Pulitzer Prize-winning author and cancer physician at Columbia University Medical Center.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It’s time to fundamentally improve the cancer journey, while ensuring that resources are used more wisely. The pandemic showed that the healthcare system can respond and evolve when confronted by an existential threat
Government-funded initiatives such as the Cancer Moonshot support not only the primary science that often serves as a foundation for medical advances, but also ensure that patients with rare cancers are not overlooked.
What would happen if we attacked cancer from an agnostic, 10,000-foot point of view? As president of the Biden Cancer Initiative, Greg Simon is determined to find out.
In 12 months, the Cancer Moonshot has made great strides, secured $1.8 billion in funding and seeded countless projects, partnerships, and possibilities. One year on, a new administration has the power to undo it all.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.